Cargando…

Hydroxychloroquine prophylaxis for SARS-CoV-2 infection among healthcare workers

Detalles Bibliográficos
Autores principales:	Karim, Habib M.R., Ahmed, Ghazal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853259/ https://www.ncbi.nlm.nih.gov/pubmed/32773410 http://dx.doi.org/10.4103/ijmr.IJMR_2372_20

Ejemplares similares

Interpreting the impact of hydroxychloroquine prophylaxis on SARS-CoV-2 infection
por: Yadav, Reetika Malik, et al.
Publicado: (2021)

Observations on healthcare workers & SARS-CoV-2 infection
por: Barde, Prajak, et al.
Publicado: (2020)

Observations on article on healthcare workers & SARS-CoV-2 infection
por: Kulkarni, A.P.
Publicado: (2020)

Side effects of hydroxychloroquine prophylaxis against COVID-19 in healthcare workers
por: Dixit, Prashant Kumar, et al.
Publicado: (2021)

SARS-CoV-2 infection among healthcare workers in India: Limitations of the case-control investigation
por: Niranjan, Viswanathan, et al.
Publicado: (2020)

Point prevalence of SARS-CoV-2 infection among healthcare workers in March and June 2023 in Sweden
por: Blom, Kim, et al.
Publicado: (2023)

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
por: Liu, Jia, et al.
Publicado: (2020)

Serosurvey for Health-Care Workers Provides Supportive Evidence for the Effectiveness of Hydroxychloroquine Prophylaxis against SARS-CoV-2 Infection
por: Yadav, Reetika Malik, et al.
Publicado: (2021)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Prophylactic use of hydroxychloroquine among healthcare workers in a case-control study
por: Kunte, Renuka, et al.
Publicado: (2020)

Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
por: Galvis, Virgilio, et al.
Publicado: (2020)

SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis
por: Dousa, Khalid M., et al.
Publicado: (2020)

Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
por: Galvis, Virgilio, et al.
Publicado: (2020)

Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis
por: Faruqui, Atiya R., et al.
Publicado: (2021)

Hydroxychloroquine prophylaxis for COVID-19 contacts in India
por: Rathi, Sahaj, et al.
Publicado: (2020)

A Study on Hydroxychloroquine (HCQ) as prophylaxis among Health care worker (HCW) for SARS -Co V-2 infection
por: Ghosh, Anindya, et al.
Publicado: (2021)

Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection
por: Lechner, Matt, et al.
Publicado: (2020)

SARS-CoV-2 Infection after Vaccination in Health Care Workers in California
por: Keehner, Jocelyn, et al.
Publicado: (2021)

Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2
por: Neves, Fabricio Souza
Publicado: (2020)

Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19
por: Mazzitelli, Maria, et al.
Publicado: (2020)

Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
por: Pareek, Anil, et al.
Publicado: (2020)

Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models
por: Rosenke, Kyle, et al.
Publicado: (2020)

SARS-CoV-2 shedding and infectivity
por: Atkinson, Barry, et al.
Publicado: (2020)

SARS-CoV-2 Infection in Children
por: Lu, Xiaoxia, et al.
Publicado: (2020)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

Predictors for Severity of SARS-CoV-2 Infection Among Healthcare Workers
por: El-Raey, Fathiya, et al.
Publicado: (2021)

Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation
por: Wang, Pei-Gang, et al.
Publicado: (2020)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?
por: Mehta, Sudhir, et al.
Publicado: (2020)

Prevalence of SARS-Cov-2 Antibodies in Emergency Medicine Healthcare Workers
por: Wang, Ralph C., et al.
Publicado: (2021)

SARS-CoV-2 seropositivity among non-medical frontline workers in Pune, Maharashtra, India
por: Deoshatwar, Avinash R., et al.
Publicado: (2022)

SARS-CoV-2 infection in conjunctival tissue
por: Liu, Yu-Chi, et al.
Publicado: (2020)

Dysbiosis in SARS-CoV-2–Infected Patients
por: Marazzato, Massimiliano, et al.
Publicado: (2021)

Arthritis after SARS-CoV-2 infection
por: Baimukhamedov, Chokan, et al.
Publicado: (2021)

Neuropathology associated with SARS-CoV-2 infection
por: Glatzel, Markus, et al.
Publicado: (2021)

Neuropathology associated with SARS-CoV-2 infection
por: Egervari, Kristof, et al.
Publicado: (2021)

Neuropathology associated with SARS-CoV-2 infection
por: Nasrallah, MacLean P, et al.
Publicado: (2021)

Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing
por: Tu, Yuan-Po, et al.
Publicado: (2020)

Persistent hesitancy for SARS-CoV-2 vaccines among healthcare workers in the United Kingdom: analysis of longitudinal data from the UK-REACH cohort study
por: Martin, Christopher A., et al.
Publicado: (2022)

Transplacental transmission of SARS-CoV-2 infection via NRP1
por: El-Arabey, Amr Ahmed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_29iqb96k9k630ja2ellp8g2qb5